Ethnic origin is unrelated to autoimmunity and residual pancreatic function in 471 youth with clinically diagnosed type 2 diabetes

Pediatric Diabetes

Volumn 10, Issue 4, 2009, Pages 240-247

  Gottschalk, Michael ^a   Danne, Thomas ^b   Fuerst Recktenwald, Sabine ^c  

^a UCSD MEDICAL CENTER   (United States)

^b KINDERKRANKENHAUS AUF DER BULT   (Germany)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Glimepiride; Metformin; Pediatric; Type 2 diabetes mellitus

Indexed keywords

AUTOANTIBODY; C PEPTIDE; GLUTAMATE DECARBOXYLASE ANTIBODY; HEMOGLOBIN A1C; INSULIN; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; AGE DISTRIBUTION; ANTIBODY SCREENING; ANTIBODY TITER; AUTOIMMUNITY; CHILD; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISEASE DURATION; ETHNICITY; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS FUNCTION; PHENOTYPE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SEX RATIO;

ADMINISTRATION, ORAL; ADOLESCENT; ALGORITHMS; AUTOIMMUNITY; CHILD; DIABETES MELLITUS, TYPE 2; DRUG COMBINATIONS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; PANCREAS; SULFONYLUREA COMPOUNDS;

EID: 66649106055     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2008.00489.x     Document Type: Review

References (24)

1. American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care 2000: 23: 381-389.
2. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1998: 21: S5-S19.
3. Rosenbloom AL. Obesity, insulin resistance, beta-cell autoimmunity, and the changing clinical epidemiology of childhood diabetes. Diabetes Care 2003: 26: 2954-2956.
4. Juneja R, Palmer JP. Type 1 1/2 diabetes: Myth or reality? Autoimmunity 1999: 29: 65-83.
5. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N Engl J Med 2000: 342: 301-307.
6. Tuomilehto J, Yliharsila H. Antibodies as predictors of insulin-dependent diabetes mellitus before the clinical onset. Nutrition 1998: 14: 403-405.
7. Boehm BO, Manfras B, Seissler J et al. Epidemiology and immunogenetic background of islet cell antibody-positive nondiabetic schoolchildren. Ulm-Frankfurt population study. Diabetes 1991: 40: 1435-1439.
8. Kondrashova A, Viskari H, Kulmala P et al. Signs of beta-cell autoimmunity in nondiabetic schoolchildren: A comparison between Russian Karelia with a low incidence of type 1 diabetes and Finland with a high incidence rate. Diabetes Care 2007: 30: 95-100.
9. Turner R, Stratton I, Horton V et al. UKPDS 25: Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 1997: 350: 1288-1293.
10. Umpaichitra V, Banerji MA, Castells S. Autoantibodies in children with type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2002: 15 (Suppl. 1): 525-530.
11. Gottschalk M, Danne T, Vlajnic A, Cara JF. Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: A randomized, single-blind comparative study. Diabetes Care 2007: 30: 790-794.
12. Bacha F, Gungor N, Arslanian SA. Measures of beta-cell function during the oral glucose tolerance test, liquid mixed-meal test, and hyperglycemic clamp test. J Pediatr 2008: 152: 618-621.
13. Blondell RD, Foster MB, Dave KC. Disorders of puberty. Am Fam Physician 1999: 60: 209-214.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985: 28: 412-419.
15. Juneja R, Hirsch IB, Naik RG, Brooks-worrell BM, Greenbaum CJ, Palmer JP. Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes. Metabolism 2001: 50: 1008-1013.
16. Sellers E, Eisenbarth G, Young TK, Dean HJ. Diabetes-associated autoantibodies in aboriginal children. Lancet 2000: 355: 1156.
17. Hathout EH, Thomas W, El Shahawy M, Nahab F, Mace JW. Diabetic autoimmune markers in children and adolescents with type 2 diabetes. Pediatrics 2001: 107: E102-E105.
18. Reinehr T, Schober E, Wiegand S, Thon A, Holl R. Beta-cell autoantibodies in children with type 2 diabetes mellitus: Subgroup or misclassification? Arch Dis Child 2006: 91: 473-477.
19. Libman IM, Pietropaolo M, Arslanian SA, Laporte RE, Becker DJ. Evidence for heterogeneous pathogenesis of insulin-treated diabetes in black and white children. Diabetes Care 2003: 26: 2876-2882.
20. Brooks-worrell BM, Greenbaum CJ, Palmer JP, Pihoker C. Autoimmunity to islet proteins in children diagnosed with new-onset diabetes. J Clin Endocrinol Metab 2004: 89: 2222-2227.
21. Gottsater A, Landin-olsson M, Lernmark A, Fernlund P, Sundkvist G. Islet cell antibodies are associated with β-cell failure also in obese adult onset diabetic patients. Acta Diabetol 1994: 31: 226-231.
22. Kasuga A, Maruyama T, Ozawa Y et al. Antibody to the M(r) 65,000 isoform of glutamic acid decarboxylase are detected in non-insulin-dependent diabetes in Japanese. J Autoimmun 1996: 9: 105-111.
23. Groop LC, Bottazzo GF, Doniach D. Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis. Diabetes 1986: 35: 237-241.
24. Butler AE, Janson J, Bonner-weir S, Ritzel R, Rizza RA, Butler PC. B-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003: 52: 102-110.